Bedford Labs Recalls Vecuronium Bromide

Bedford Laboratories is voluntarily recalling one lot of Vecuronium Bromide due to the discovery of particulate matter in a small number of vials.

The recall applies to all 20 mg vials of injectable Vecuronium Bromide from lot 2067134, shipped between 8/8/2011 to 11/9/2011, according to a company press release.

Vecuronium Bromide is given along with general anesthesia to assist with endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation, according to the Food and Drug Administration.

The discovery was made during a post-release inspection.

The drug manufacturer has not received any reports of adverse events. However, adverse reactions may include vein irritation and phlebitis, clinically occult pulmonary garnulomas detected at routine autopsy examination, local tissue infarction, and severe pulmonary dysfunction, oclusion of capillaries and arteries, anaphylactic shock and death.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you. For legal help, call (800) 581-6358.

Tags: